Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

YOU WONT BELIEVE: 52 | Mind Blowing Facts

NiSource (NYSE:NI) reaffirmed its 2026 earnings outlook and raised its long-term growth expectations after reporting first-quarter adjusted earnings that management said reflected regulatory execution, infrastructure investment recovery and growing momentum in its data center strategy. The regulate

MarketBeat

Beta Bionics Touts Pharmacy Push, iLet Momentum and 2027 Mint Patch Pump Plans

Beta Bionics (NASDAQ:BBNX) Chief Financial Officer Stephen Feider said the company’s first-quarter outperformance was supported by increasing use of the pharmacy reimbursement channel, expanded sales coverage and growing confidence in the company’s iLet insulin pump platform. Speaking at a Bank of

MarketBeat

Nomad Foods Q1 Earnings Call Highlights

Nomad Foods (NYSE:NOMD) reported first-quarter 2026 results that management said were slightly ahead of internal expectations, despite lower organic revenue, margin pressure and a sharp year-over-year decline in adjusted EBITDA. Chief Executive Officer Dominic Brisby, speaking on his second quarter

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

Ingevity Q1 Earnings Call Highlights

Ingevity (NYSE:NGVT) reported higher first-quarter 2026 sales and reaffirmed its full-year outlook as management highlighted progress on portfolio simplification, strong margins in its Performance Materials business and continued share repurchases. On the company’s earnings call, President and CEO

MarketBeat

Natural Grocers by Vitamin Cottage Q2 Earnings Call Highlights

Natural Grocers by Vitamin Cottage (NYSE:NGVC) reported modest sales growth and higher earnings for its fiscal second quarter, as management said disciplined expense controls and store execution helped offset a more cautious consumer environment. On the company’s earnings call, Chairman and Co-Pres

MarketBeat

BridgeBio Pharma Touts Attruby Blockbuster Path, 3 Potential Pipeline Launches

BridgeBio Pharma (NASDAQ:BBIO) executives used a BofA healthcare conference appearance in Las Vegas to reiterate confidence in the commercial trajectory of Attruby and outline expectations for three potential near-term product launches from the company’s late-stage pipeline. Tom Trimarchi, BridgeBi

MarketBeat

Lithium Americas (Argentina) Q1 Earnings Call Highlights

Lithium Americas (Argentina) (NYSE:LAAC) reported a stronger first quarter for 2026, with Chief Executive Officer Sam Pigott saying the company’s Caucharí-Olaroz lithium operation continued to run near design capacity while beginning to generate “meaningful cash flow.” On the earnings call, Pigott

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

Natural Gas Services Group Q1 Earnings Call Highlights

Natural Gas Services Group (NYSE:NGS) reported a record first quarter, with management citing higher utilization, large-horsepower fleet additions and continued pricing discipline as key drivers of the compression equipment provider’s performance. Chief Executive Officer Justin Jacobs said the comp

MarketBeat

Madison Air Solutions Q1 Earnings Call Highlights

Madison Air Solutions (NYSE:MAIR) reported first-quarter 2026 results in its first earnings call as a public company, highlighting double-digit pro forma sales and earnings growth, strong commercial demand and a record backlog following its recent initial public offering. President and CEO Jill Wya

MarketBeat

Karman Q1 Earnings Call Highlights

Karman (NYSE:KRMN) reported record fiscal first-quarter results and raised its full-year outlook, citing broad-based growth across its legacy markets, contributions from recent acquisitions and increasing demand tied to defense, space launch and maritime programs. Chief Executive Officer Jon Rambea

MarketBeat

Janus International Group Q1 Earnings Call Highlights

Janus International Group (NYSE:JBI) reported first-quarter results that topped management’s internal expectations despite what executives described as a still-challenging macroeconomic backdrop, with softness continuing in North American self-storage new construction and parts of the commercial doo

MarketBeat

Kayne Anderson BDC Q1 Earnings Call Highlights

Kayne Anderson BDC (NYSE:KBDC) reported first-quarter 2026 net investment income of $0.43 per share, covering its $0.40 quarterly dividend by 108%, as management emphasized the company’s defensive portfolio positioning and disciplined lending approach amid a more uncertain private credit environment

MarketBeat

GCT Semiconductor Q1 Earnings Call Highlights

GCT Semiconductor (NYSE:GCTS) reported higher first-quarter revenue and said its 5G chipset commercialization efforts continued to gain traction, with management pointing to increased shipments, broader customer engagement and progress across fixed wireless access, Internet of Things and non-terrest

MarketBeat

B&G Foods Q1 Earnings Call Highlights

B&G Foods (NYSE:BGS) reported a first-quarter loss as divestiture-related charges weighed on results, while management said the company is making progress reshaping its portfolio toward higher-margin businesses and reducing leverage. On the company’s fiscal first-quarter 2026 earnings call, Chief E

MarketBeat

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

Andersen Group Q1 Earnings Call Highlights

Andersen Group (NYSE:ANDG) reported first-quarter 2026 revenue and adjusted EBITDA above its prior guidance, with management pointing to broad-based organic growth across tax service lines, higher revenue per professional and an active acquisition pipeline expected to contribute more meaningfully in

MarketBeat

Astrana Health Says Prospect Deal Is Ahead of Schedule as Q1 Trends Beat Expectations

Astrana Health (NASDAQ:ASTH) CEO and President Brandon Sim said the value-based care company is seeing early benefits from its acquisition of Prospect, while reporting stronger-than-expected first-quarter trends across medical costs, free cash flow and revenue. Speaking at a Bank of America healthc

MarketBeat

a.k.a. Brands Q1 Earnings Call Highlights

a.k.a. Brands (NYSE:AKA) reported a stronger-than-expected start to fiscal 2026, with first-quarter net sales rising 3% to $132.5 million and Adjusted EBITDA increasing to $5.1 million, management said on the company’s earnings call. Chief Executive Officer Ciaran Long said the results reflected “s

MarketBeat

Verrica Pharmaceuticals Q1 Earnings Call Highlights

Verrica Pharmaceuticals (NASDAQ:VRCA) reported higher first-quarter revenue and record demand for its molluscum contagiosum treatment YCANTH, while outlining progress on late-stage development programs in common warts and basal cell carcinoma. President and Chief Executive Officer Jayson Rieger sai

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

Upexi Q3 Earnings Call Highlights

Upexi (NASDAQ:UPXI) reported higher fiscal third-quarter revenue but a large net loss tied primarily to unrealized losses on its Solana holdings, as management said a weak crypto market weighed on both token prices and industry valuation multiples during the quarter ended March 31, 2026. Chief Exec

MarketBeat

TriSalus Life Sciences Q1 Earnings Call Highlights

TriSalus Life Sciences (NASDAQ:TLSI) reported slightly lower first-quarter revenue and reduced its full-year 2026 revenue outlook, citing disruption from a broad commercial reorganization and a delayed FDA review for its next-generation TriNav Advance device. President and Chief Executive Officer M

MarketBeat

Paysign Q1 Earnings Call Highlights

Paysign (NASDAQ:PAYS) reported what executives described as the strongest start to a year in the company’s history, with first-quarter 2026 revenue rising 50.8% year over year to $28 million and profitability expanding sharply as its patient affordability business became its largest revenue contribu

MarketBeat

Relmada Therapeutics Q1 Earnings Call Highlights

Relmada Therapeutics (NASDAQ:RLMD) said it remains on track to begin its Phase 3 RESCUE registrational program for NDV-01 in mid-2026 after reporting 12-month Phase 2 data in non-muscle invasive bladder cancer and strengthening its balance sheet through a private financing. On the company’s first-q

MarketBeat

QuickLogic Q1 Earnings Call Highlights

QuickLogic (NASDAQ:QUIK) reported higher first-quarter fiscal 2026 revenue and reiterated expectations for strong full-year growth, as management highlighted progress in radiation-hardened FPGA products, embedded FPGA intellectual property and chiplet-related opportunities. President and Chief Exec

MarketBeat

OptimizeRx Q1 Earnings Call Highlights

OptimizeRx (NASDAQ:OPRX) reported first-quarter fiscal 2026 results that topped consensus expectations, while management lowered its full-year revenue outlook, citing continued caution among life sciences customers and shorter contract commitments tied in part to most-favored-nation pricing dynamics

MarketBeat

Nyxoah Q1 Earnings Call Highlights

Nyxoah (NASDAQ:NYXH) reported 13% sequential worldwide net revenue growth in the first quarter of 2026, driven primarily by continued adoption of its Genio system in the United States, where the company is in its second full quarter of commercialization. Chief Executive Officer Olivier Taelman said

1 … 51 52 53 54

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Intellectual Property

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.